Hassan Aliashrafzadeh

I am a physician (Tabriz University, School of Medical Sciences, 2020) with over three years of experience in Iranian health and research centers, including impactful contributions during the COVID-19 pandemic. My research interests focus on neurological diseases, particularly their impact on the quality of life. I have co-authored publications on traumatic brain injuries, cancer, antitumor agents, and COVID-19, with further publications on kinase inhibitors and stroke in preparation. I am eager to contribute my clinical and research skills to a leading scientific group, enhancing my scientific communication and networking for a successful future career in neurology research

• Recognized for saving lives of pregnant women at Keshavarz Health Center, 03/01/21
• Recognized for efforts during the COVID-19 pandemic, 01/01/21

• Journal of Exploration of Drug Science
• Frontiers in Pharmacology

• Karkon-Shayan S, Aliashrafzadeh H, et al., Resveratrol as an antitumor agent for glioblastoma multiforme..., Acta Histochemica, 08/01/23
• Moazamiyanfar R, Rezaei S, Aliashrafzadeh H, et al., Nobiletin in cancer therapy..., Curr Pharm Des, 04/01/23
• Naseri K, Aliashrafzadeh H, et al., Human Responses in Public Health Emergencies for Infectious Disease Control..., Contrast Media & Molecular Imaging, 09/01/22
• Shayan SK, Aliashrafzadeh H, et al., Comparison of the Outcome of Altplas Administration after Acute Ischemic Stroke..., Journal of Pharmaceutical Negative Results, 09/01/22

• Traumatic Brain Injuries (TBI)
• Acute Ischemic Stroke
• Alzheimer's Disease
• Parkinson's Disease
• Seizure
• Anti-tumor Agents and Cancers
• Drug Resistance
• Glioblastoma Multiforme
• Hypoxic-Ischemic Disease
• COVID-19
• Cardiovascular Disease
• Cardiac Arrhythmias